synthetic chemistry

Acme Bioscience, Inc., a Frontage Company, is a chemistry CRO (contract research organization) established in 2001 in California, USA, with China operations in Shanghai since 2009. It provides discovery chemistry, medicinal chemistry, process chemistry research & development, and chemical manufacturing services for biopharmaceutical companies worldwide, with experience in antiviral and anti-bacterial research.

analytical services (HPLC, LCMS, NMR, X-ray, chiral analysis and separation)chemical manufacturingchiral synthesis and chiral separationFTE servicesmedicinal chemistryprocess chemistry research & developmentroute selection and optimization

ASAKE Biotechnology, LLC is a privately held company based in Athens, Ohio, founded in 2020, that researches and develops novel health therapeutics utilizing natural resources. It specializes in biosynthetic technology and synthetic chemistry as well as emerging technologies including Proteolysis Targeting Chimeras (PROTAC), with research centered on infectious diseases, diabetes, and cancer.

bioanalytical chemistrybiosynthetic technologydrug design and synthesisgene editingProteolysis Targeting Chimeras (PROTAC)

Ashwin-Ushas Corporation is a developer of advanced technologies in the defense, aerospace, space, materials, and environmental fields. Founded in 1992 as a research company, it operates a state-of-the-art research laboratory with multidisciplinary capabilities in chemistry, synthetic chemistry, electrochemistry, polymer chemistry, materials science, aerospace testing, electronics engineering, and microbiology. It holds a worldwide patent portfolio and has served clients including the U.S. Department of Defense, NASA, NIH, and Lockheed Martin.

aerospace testingelectrochemistryelectronics engineeringmaterials scienceMicrobiologypolymer chemistryresearch and development

BioAscent is a provider of integrated drug discovery services based at the former Organon/MSD R&D site in Newhouse, Scotland, UK. Founded in 2013, its services include assay development, target analysis, compound screening, medicinal and synthetic chemistry, computational chemistry, DMPK, protein science and compound management, with access to in-house diversity and fragment libraries.

assay developmentbiophysicscompound managementcompound screeningcompound storage and logisticscomputational chemistryDMPKhigh throughput screeningin silico discoveryLC-MSliquid handlingmedicinal chemistryNMRprotein productionpurificationstructural biologysurface plasmon resonance

Broad Capabilities. Boutique Services. Every program deserves a partner, not just a provider. We built Bio Duro to be exactly the right size: broad enough to support your science at every stage, agile enough to move when you need to move, and focused enough to treat your program like the priority it is. Explore Our Capabilities All Company News October 1, 2026 June 6, 2026 May 28, 2026 April 28, 2026 April 23, 2026 March 12, 2026 March 3, 2026 February 10, 2026 January 27, 2026 November 18, 2025 August 20, 2025 July 30, 2025 June 10, 2025 May 8, 2025 April 7, 2025 March 25, 2025 March 5, 2025 January 20, 2025 January 9, 2025 January 6, 2025 October 24, 2024 October 1, 2024 September 16, 2024 All Company News Deliver solutions using enabling technologies like AI enabled molecular design, high throughput screening, DNA-coded library, parallel synthesis. Explore Chemistry Most visited.

AI-assisted molecular designanalytical chemistryAPI manufacturingbioanalysiscomputational chemistryDMPKDNA-encoded library screeningdrug product manufacturingformulation developmenthigh throughput screeningin vitro assaysin vivo modelsmedicinal chemistryparallel synthesispeptide chemistryprocess R&DScale uptoxicology

DEL Source provides small molecule DNA-Encoded Library (DEL) solutions enhanced with AI/ML capabilities to accelerate drug discovery and identification of novel chemical leads. Backed by drug discovery experts with over 100 years of combined experience across DEL technologies, Medicinal Chemistry, and Discovery Biology, it offers comprehensive DEL libraries and hit identification services, with labs in Cambridge, Massachusetts and Bangalore, India.

AI/ML-enhanced library designcustom synthesis of tailored DEL librariesDEL screening and hit identificationDNA-Encoded Library (DEL) synthesishit re-synthesis and activity confirmation

ExciPlex, Inc. invents diagnostic assays, builds detection systems, and supplies critical reference materials for agricultural and environmental monitoring. The company specializes in natural toxins, supplying high purity toxins and complex small molecules, and provides specialty chemical production for high performance diagnostics. It also offers CRO and consulting services to biotech, agtech, and life sciences companies, and develops portable spectroscopic instrumentation.

assay developmentassay validationconjugation chemistryconsultingdiagnostic assay inventionlibrary design and synthesisportable spectroscopy instrumentationreaction optimizationtoxin purification

IRBM is a preclinical drug discovery organization based in Rome, Italy, conducting small molecule, peptide and antibody programs from target validation through to a preclinical candidate, either as a full integrated program or as a single capability for clients. Its scientists have contributed to three approved drugs and delivered more than thirty preclinical candidates to partners.

ADMEantibody phage displayassay developmentBioinformaticsbiophysical characterizationcompound managementcomputational chemistryDMPKfunctional genomicshigh-content screeninghigh throughput screeningin vivo pharmacologymedicinal chemistrymRNA displayNMRpeptide chemistrypeptide phage displayprotein productionstructural biology